Copyright © 1999 by Institute of Pharmacology
Polish Academy of Sciences
Pol. J. Pharmacol., 1999, 51, 201-206
ISSN 1230-6002

Go to: Contents | Previous Article | PJP - Home Page |


APPLICATION OF CALCIUM CHANNEL BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES
Zbigniew S. Herman
Department of Clinical Pharmacology, Silesian University School of Medicine, Medyków 18, PL 40-752 Katowice, Poland

Application of calcium channel blockers in the treatment of cardiovascular diseases. Z.S. HERMAN. Pol. J. Pharmacol., 1999, 51, 201-206.

In this review the calcium channel blockers (CCB) were divided into three generations. The advantages and shortcomings of these drugs were described. The application of CCB in the treatment of hypertensive disease, ischaemic heart disease, congestive heart failure and heart arrhythmias was discussed. Actually, the optimal drugs from this group are representatives of the third generation: amlodipine and lacidipine. It seems that search for new CCB should be directed to find the substances similar to or better than the chemical entities of this third generation. The calcium sensitizing agents as a new positive inotropic drugs are signalled. The possibility that in the future the new CCB could have an application as psychotropic drugs is mentioned.

Key words: calcium channel blockers, amlodipine, lacidipine, cardiovascular diseases

Back to: Top | PJP - Home Page |